Who
Michael F. Mahoney
Chairman, President & CEO
Company insider
Files Form 4 as: Chairman, President & CEO, Boston Scientific; Director, CVS Health; Director, Baxter International.
In numbers
- Trades disclosed
- 461
- Buys
- 5
- Sells
- 29
- Bought
- $20.8M
- Sold
- $237.4M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 1 Nov 2011
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Bought | $9.0M186,240 at $48.33 | filing |
| 3 Aug 2026filed 5 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code I | $1.1M22,119 at $48.43 | filing |
| 3 Aug 2026filed 5 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Bought | $9.0M186,240 at $48.33 | filing |
| 3 Aug 2026filed 5 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code I | $1.1M22,119 at $48.43 | filing |
| 28 May 2026filed 1 Jun 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code G | —386,755 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code G | —386,755 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $169K1,737.005 at $97.15 | filing |
| 14 May 2026filed 15 May 2026 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $169K1,737 at $97.15 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —16,265 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —16,265 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —16,265 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $588K7,865 at $74.73 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —16,265 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $588K7,865 at $74.73 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —16,524 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —16,524 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —16,524 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $597K7,990 at $74.73 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —16,524 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $597K7,990 at $74.73 | filing |
News
Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026Financial Contrast: Sysmex (OTCMKTS:SSMXY) and Boston Scientific (NYSE:BSX)BSX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Michael F. Mahoney; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.